Potassium binder may unlock lifesaving heart drugs for seniors
NCT ID NCT06578078
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a potassium-lowering drug called sodium zirconium cyclosilicate (Lokelma) can help elderly patients with heart failure and chronic kidney disease safely take higher doses of RAASi medications, which are often limited by high potassium levels. The trial will enroll 94 people aged 70 and older, comparing those who get Lokelma plus standard RAASi therapy to those who get standard care alone. The main goal is to see if more patients can increase their RAASi dose by at least 25% over three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Sodium Zirconium Cyclosilicate (Lokelma)
- What this could lead to
- If successful, this could show a way to safely use life-saving heart and kidney medications in elderly patients who currently cannot due to high potassium levels.
- What could go wrong
- This is a small, early-phase trial (94 participants) focused on medication dosing, not hard outcomes like survival. The drug may not meaningfully improve long-term health.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Clínico Universitario de Valencia
RECRUITINGValencia, 46010, Spain
-
Hospital Universitario Fundación Alcorcón
NOT_YET_RECRUITINGAlcorcón, Madrid, 28922, Spain
-
Hospital Universitario Nuestra Señora del Perpétuo Socorro
RECRUITINGAlbacete, 02006, Spain
-
Hospital Universitario Reina Sofía
NOT_YET_RECRUITINGCórdoba, 14004, Spain
-
Hospital Universitario Severo Ochoa
NOT_YET_RECRUITINGLeganés, Madrid, 28914, Spain
-
Hospital Universitario de Burgos
RECRUITINGBurgos, 09006, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Digital nurse companion: could an app ease the burden of chronic illness?
- Could continuing a common heart drug before surgery save lives?
- Poles apart? nordic walking may outpace standard rehab for heart failure
- Could a gentler tug on the Heart's reins spark recovery?
- Can slow breathing soothe a failing heart?
- Can a new graft keep dialysis access working longer?